Bioprinting is rapidly moving from research labs into commercial reality, and it is reshaping how the pharmaceutical and ...

A research team reports a promising new strategy: combining two already-approved drugs—silybin, a natural liver-protective ...

A combination of silybin and carvedilol for treating liver fibrosis is more effective than either drug alone. | Drug ...

The study used large-scale CRISPR gene-editing technology to systematically determine which genes are required as embryonic ...

San Diego, California, U.S.A.-based food tech startup BlueNalu announced it has garnered a USD 11 million (EUR 9.4 million) ...

Transverse tubules (T-tubules) play a significant role in muscle contraction. However, the underlying mechanism of their ...

True patient-centricity will drive commercial success as CGT moves beyond first-generation therapies. Current timelines in CGT, from diagnosis to treatment, can exceed six months, often compounded by ...

Real-world testing involving 12 electric vehicle models and 100 sample batteries across four major Chinese cities showed that ...

The agreement establishes a dual-source supply chain to support regulatory compliance for TOYO’s solar manufacturing operations in Ethiopia and the United States.

Brisbane-based Vaxxas has appointed David Peacock to lead the push to bring its vaccine patch technology to market.

Triple-negative breast cancer (TNBC) is among the most aggressive types of breast cancer, lacking estrogen, progesterone, and ...

Semi-solid-state (solid-liquid hybrid) battery energy storage is transitioning from technical validation to large-scale commercialization.